Blue water biotech, inc. announces notification from nasdaq related to delayed quarterly report on form 10-q

Cincinnati, aug. 28, 2023 (globe newswire) -- blue water biotech, inc. (“blue water” or the “company”), a biotechnology and pharmaceutical company spanning multiple sectors, today announced that it received a delinquency notification letter (“notice”) from the listing qualifications staff of the nasdaq stock market llc (“nasdaq”) on august 22, 2023 due to the company's non-compliance with nasdaq listing rule 5250(c)(1) as a result of the company's failure to timely file its quarterly report on form 10-q for the fiscal quarter ended june 30, 2023 (the “form  10 - q”). nasdaq listing rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the securities and exchange commission (the “sec”).
BWV Ratings Summary
BWV Quant Ranking